(Q33338797)

English

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

Christopher Griffiths

6

object named as

C E Griffiths

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

S Reitamo

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Spuls

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

B Sassolas

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Lahfa

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Claudy

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sirolimus European Psoriasis Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

145

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

438-445

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

Rapamycin: a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

Rapamycin: FK506's fraternal twin or distant cousin?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04376.X

21 January 2018

Identifiers

10.1046/J.1365-2133.2001.04376.X

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33338797&oldid=2046523726"